We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PODD market cap is 16.69B. The company's latest EPS is USD 5.9565 and P/E is 39.80.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 509.8M | 441.7M | 488.5M | 543.9M | 597.5M |
| Operating Income | 106.4M | 56.9M | 51.2M | 88.1M | 109.3M |
| Net Income | 103.3M | 51.5M | 188.6M | 77.5M | 100.7M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 904.4M | 1.1B | 1.31B | 1.7B | 2.07B |
| Operating Income | 51.5M | 126M | 37.6M | 220M | 308.9M |
| Net Income | 6.8M | 16.8M | 4.6M | 206.3M | 418.3M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.59B | 2.62B | 2.88B | 3.03B | 3.09B |
| Total Liabilities | 1.86B | 1.83B | 1.88B | 1.91B | 1.88B |
| Total Equity | 732.7M | 790.7M | 998.4M | 1.12B | 1.21B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.87B | 2.05B | 2.25B | 2.59B | 3.09B |
| Total Liabilities | 1.27B | 1.49B | 1.77B | 1.86B | 1.88B |
| Total Equity | 603.6M | 556.3M | 476.4M | 732.7M | 1.21B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 145.7M | 87.6M | 184.1M | 282.6M | 430.3M |
| Investing | -119.4M | -24M | -48.9M | -78.2M | -146.2M |
| Financing | -13.6M | -14.1M | -15M | -7.2M | -28.1M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 84M | -68.1M | 119M | 145.7M | 430.3M |
| Investing | 14M | -82.7M | -191.1M | -119.4M | -146.2M |
| Financing | 605.5M | 40.7M | -40.3M | -13.6M | -28.1M |
| Market Cap | 16.69B |
| Price to Earnings Ratio | 39.80 |
| Price to Sales Ratio | 8.04 |
| Price to Cash Ratio | 17.46 |
| Price to Book Ratio | 13.74 |
| Dividend Yield | - |
| Shares Outstanding | 70.23M |
| Average Volume (1 week) | 994.78k |
| Average Volume (1 Month) | 890.29k |
| 52 Week Change | 33.16% |
| 52 Week High | 289.46 |
| 52 Week Low | 160.19 |
| Spread (Intraday) | 4.5 (1.86%) |
| Company Name | Insulet Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.insulet.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
